Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine human chorionic gonadotropin before embryo transfer in IVF/ICSI
IRCT20160703028756N7Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of human chorionic gonadotropin in infertility (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: AMH, Chemical pregnancy and 6 more. Started Aug 2021; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
infertility
Beyond the preview
Go deeper on IRCT20160703028756N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160703028756N7.